Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 27
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Musculoskelet Surg ; 2024 Jul 18.
Article de Anglais | MEDLINE | ID: mdl-39026047

RÉSUMÉ

INTRODUCTION: Elbow fractures, characterized by their complexity, present significant challenges in post-surgical recovery, with rehabilitation playing a critical role in functional outcomes. This study explores the efficacy of rehabilitative interventions in enhancing joint range of motion (ROM) and reducing complications following surgery for both stable and unstable elbow fractures. METHODS: A cohort of 15 patients, divided based on the stability of their elbow fractures and whether they received post-operative rehabilitation, was analyzed retrospectively. Measurements of ROM-including flexion, extension, pronation, and supination-were taken at three follow-ups: 15-, 30-, and 45-day post surgery. The study assessed the impact of rehabilitation on ROM recovery and the resolution of post-surgical complications. RESULTS: The findings indicated no statistically significant differences in ROM improvements between patients who underwent rehabilitation and those who did not, across all types of movements measured. However, early rehabilitative care was observed to potentially aid in the mitigation of complications such as joint stiffness, especially in patients with stable fractures. CONCLUSION: While rehabilitation did not universally improve ROM recovery in elbow fracture patients, it showed potential in addressing post-operative complications. The study underscores the importance of individualized rehabilitation plans and highlights the need for further research to establish evidence-based guidelines for post-surgical care in elbow fractures.

2.
Reumatismo ; 76(1)2024 Mar 22.
Article de Anglais | MEDLINE | ID: mdl-38523583

RÉSUMÉ

OBJECTIVE: Melorheostosis is a rare, non-hereditary, benign bone disease characterized by abnormal bone growth. Generally, melorheostosis develops during childhood or adolescence and progresses gradually over time. This disease represents a true challenge to the physician because of its variability due to location, extension of the affected bone, and involvement of associated soft tissue. Pain management, physical therapy, and surgery may be recommended, depending on the individual case. This review aims to get an overview of the latest evidence relating to epidemiology, clinical and radiographic characteristics, diagnosis, and possible therapeutic strategies for melorheostosis and describe our experience through a clinical case. METHODS: We designed a comprehensive literature search on melorheostosis in MEDLINE (via Pubmed) up to April 2023 and reviewed reports published in international journals. RESULTS: The purpose is to highlight the importance of a multidisciplinary approach in the management of a rare disease such as melorheostosis. We discuss the role of different physicians, including genetists, rheumatologists, physiatrists, physical therapists, and orthopedic surgeons, in providing accurate diagnoses and effective treatments. We conducted a comprehensive review of the literature on the treatment of melorheostosis to support these findings. In addition, the article presents a case study of a patient suffering from melorheostosis, focusing on difficulties in reaching a correct diagnosis and attempts towards conservative and surgical interventions. The patient underwent hip arthroplasty, and the final result was an improvement in function and a reduction in pain. CONCLUSIONS: Managing melorheostosis can be challenging, and there is no standardized treatment for this condition at the moment.


Sujet(s)
Mélorhéostose , Adolescent , Humains , Mélorhéostose/complications , Mélorhéostose/chirurgie , Mélorhéostose/diagnostic , Douleur , Gestion de la douleur , Résultat thérapeutique , Maladies rares
3.
J Plast Surg Hand Surg ; 56(5): 255-260, 2022 Oct.
Article de Anglais | MEDLINE | ID: mdl-34431757

RÉSUMÉ

The treatment of trapeziometacarpal (TM) osteoarthritis is still debated, as many surgical options are available, and no technique has proven to be superior. Prosthetic treatment in this context has been described since the early 60s. Recently, the use of pyrolytic carbon-based prosthesis has revolutionized arthroplasty surgery in the hand. We performed a retrospective investigation of our surgical management of TM osteoarthritis since 2010 including the study only patients treated with partial trapeziectomy and Pyrodisk implant, with at least 5 years follow-up. After the application of inclusion criteria, 26 patients (6 males and 20 females) were retained. Despite the literature suggesting that implant TM surgery is well suited for older patients, in our experience, the procedure was mainly proposed to the young manual worker, with high demands in terms of thumb strength and stability (mean age of 53 years old, range 37-65). A statistically significant improvement in post-operative DASH, Kapandji and scores was observed. As well, strength measurements, particularly pinch strength and grip strength, increased significantly after the surgery. According to our findings, the Pyrodisk implant provides satisfactory results in terms of thumb strength and stability even in young and active patients and should therefore be considered as a valuable option in selected cases. Meticulous surgical procedure is mandatory in order to avoid complications and should therefore be executed by an expert surgeon. Abbreviation: IV: level of evidence.


Sujet(s)
Articulations carpométacarpiennes , Prothèse articulaire , Arthrose , Os trapèze , Adulte , Sujet âgé , Carbone , Articulations carpométacarpiennes/chirurgie , Femelle , Études de suivi , Humains , Mâle , Adulte d'âge moyen , Arthrose/chirurgie , Amplitude articulaire , Études rétrospectives , Pouce/chirurgie , Os trapèze/chirurgie
4.
HIV Med ; 18(10): 764-771, 2017 11.
Article de Anglais | MEDLINE | ID: mdl-28737297

RÉSUMÉ

OBJECTIVES: Frailty is a predictor of adverse health outcomes and can be measured across the life course, including among people living with HIV. The purpose of this study was to examine two commonly used measures of frailty - the frailty index (FI) and frailty phenotype - to assess common characteristics and to describe associations with multimorbidity, falls, and disability in people aging with HIV. METHODS: This was a cross-sectional observational study including 482 consecutive HIV-infected patients (mean age 53.9 ± SD 6.9 years; 75% male) attending the multidisciplinary metabolic clinic at the University of Modena, Italy. Frailty was measured with the frailty phenotype and a 37-item FI. RESULTS: The mean FI score was 0.28±0.1 and frailty phenotype categories were: 3.1% frail, 51.9% pre-frail, and 45% robust. The duration of antiretroviral therapy was significantly different across levels of frailty as measured by both frailty tools (P < 0.01), but the nadir CD4 count was only significant for the FI (P = 0.01); current CD4 count was not significantly different across frailty levels using either tool. Both frailty measures were associated with multimorbidity; the FI was associated with Instrumental Activities of Daily Living impairment and falls history, whereas the frailty phenotype was not. CONCLUSIONS: The frailty phenotype and the FI demonstrated similar characteristics in patients at a tertiary-level HIV clinic. The FI had a stronger association with age, nadir CD4 count, comorbidities, falls, and disability. Integrating frailty assessments in clinical practice will be crucial for the development of interventions in age-related conditions, including disability and falls, in older persons living with HIV.


Sujet(s)
Chutes accidentelles , Fragilité , Infections à VIH/complications , Infections à VIH/mortalité , Adulte , Sujet âgé , Comorbidité , Études transversales , Femelle , Humains , Italie/épidémiologie , Mâle , Adulte d'âge moyen
5.
J Diabetes Res ; 2016: 5281267, 2016.
Article de Anglais | MEDLINE | ID: mdl-26839893

RÉSUMÉ

This study investigated the effects of the new aldose reductase inhibitor benzofuroxane derivative 5(6)-(benzo[d]thiazol-2-ylmethoxy)benzofuroxane (BF-5m) on the prolongation of cardiac QT interval and increase of coronary perfusion pressure (CPP) in isolated, high glucose (33.3 mM D-glucose) perfused rat hearts. BF-5m was dissolved in the Krebs solution at a final concentration of 0.01 µM, 0.05 µM, and 0.1 µM. 33.3 mM D-glucose caused a prolongation of the QT interval and increase of CPP up to values of 190 ± 12 ms and 110 ± 8 mmHg with respect to the values of hearts perfused with standard Krebs solution (11.1 mM D-glucose). The QT prolongation was reduced by 10%, 32%, and 41%, respectively, for the concentration of BF-5m 0.01 µM, 0.05 µM, and 0.1 µM. Similarly, the CPP was reduced by 20% for BF-5m 0.05 µM and by 32% for BF-5m 0.1 µM. BF-5m also increased the expression levels of sirtuin 1, MnSOD, eNOS, and FOXO-1, into the heart. The beneficial actions of BF-5m were partly abolished by the pretreatment of the rats with the inhibitor of the sirtuin 1 activity EX527 (10 mg/kg/day/7 days i.p.) prior to perfusion of the hearts with high glucose + BF-5m (0.1 µM). Therefore, BF-5m supplies cardioprotection from the high glucose induced QT prolongation and increase of CPP.


Sujet(s)
Aldose reductase/antagonistes et inhibiteurs , Benzofuranes/pharmacologie , Pression sanguine/effets des médicaments et des substances chimiques , Circulation coronarienne/effets des médicaments et des substances chimiques , Cardiomyopathies diabétiques/prévention et contrôle , Antienzymes/pharmacologie , Glucose/toxicité , Rythme cardiaque/effets des médicaments et des substances chimiques , Coeur/effets des médicaments et des substances chimiques , Myocarde/enzymologie , Aldose reductase/métabolisme , Animaux , Cardiotoxicité , Cardiomyopathies diabétiques/enzymologie , Cardiomyopathies diabétiques/physiopathologie , Facteurs de transcription Forkhead/métabolisme , Coeur/physiopathologie , Inhibiteurs de désacétylase d'histone/pharmacologie , Préparation de coeur isolé , Mâle , Protéines de tissu nerveux/métabolisme , Rat Sprague-Dawley , Sirtuine-1/antagonistes et inhibiteurs , Sirtuine-1/métabolisme , Superoxide dismutase/métabolisme
6.
Neuroscience ; 312: 120-9, 2016 Jan 15.
Article de Anglais | MEDLINE | ID: mdl-26592720

RÉSUMÉ

Creatine supplementation has been shown to protect neurons from oxidative damage due to its antioxidant and ergogenic functions. These features have led to the hypothesis of creatine supplementation use during pregnancy as prophylactic treatment to prevent CNS damage, such as hypoxic-ischemic encephalopathy. Unfortunately, very little is known on the effects of creatine supplementation during neuron differentiation, while in vitro studies revealed an influence on neuron excitability, leaving the possibility of creatine supplementation during the CNS development an open question. Using a multiple approach, we studied the hippocampal neuron morphological and functional development in neonatal rats born by dams supplemented with 1% creatine in drinking water during pregnancy. CA1 pyramidal neurons of supplemented newborn rats showed enhanced dendritic tree development, increased LTP maintenance, larger evoked-synaptic responses, and higher intrinsic excitability in comparison to controls. Moreover, a faster repolarizing phase of action potential with the appearance of a hyperpolarization were recorded in neurons of the creatine-treated group. Consistently, CA1 neurons of creatine exposed pups exhibited a higher maximum firing frequency than controls. In summary, we found that creatine supplementation during pregnancy positively affects morphological and electrophysiological development of CA1 neurons in offspring rats, increasing neuronal excitability. Altogether, these findings emphasize the need to evaluate the benefits and the safety of maternal intake of creatine in humans.


Sujet(s)
Région CA1 de l'hippocampe/effets des médicaments et des substances chimiques , Créatine/pharmacologie , Dendrites/effets des médicaments et des substances chimiques , Potentialisation à long terme/effets des médicaments et des substances chimiques , Cellules pyramidales/effets des médicaments et des substances chimiques , Animaux , Animaux nouveau-nés , Créatine/administration et posologie , Femelle , Mâle , Grossesse , Rats , Rat Sprague-Dawley
7.
Mediators Inflamm ; 2014: 857958, 2014.
Article de Anglais | MEDLINE | ID: mdl-25435715

RÉSUMÉ

The study investigated the effects of the aldose reductase (AR) inhibitor benzofuroxane derivative 5(6)-(benzo[d]thiazol-2-ylmethoxy) benzofuroxane (herein referred to as BF-5m) on the biochemical and tissue alterations induced by endotoxic uveitis in rats. BF-5m has been administered directly into the vitreous, in order to assess the expression and levels of (i) inflammatory markers such as the ocular ubiquitin-proteasome system, NF-κB, TNF-α, and MCP-1; (ii) prooxidant and antioxidant markers such as nitrotyrosine, manganese superoxide dismutase (MnSOD), and glutathione peroxidase (GPX); (iii) apoptotic/antiapoptotic factors caspases and Bcl-xl; (iv) markers of endothelial progenitor cells (EPCs) recruitment such as CD34 and CD117. 5 µL of BF-5m (0.01; 0.05; and 0.1 µM) into the right eye decreased in a dose-dependent manner the LPS-induced inflammation of the eye, reporting a clinical score 1. It reduced the ocular levels of ubiquitin, 20S and 26S proteasome subunits, NF-κB subunits, TNF-α, MCP-1, and nitrotyrosine. BF-5m ameliorated LPS-induced decrease in levels of MnSOD and GPX. Antiapoptotic effects were seen from BF-5m by monitoring the expression of Bcl-xl, an antiapoptotic protein. Similarly, BF-5m increased recruitment of the EPCs within the eye, as evidenced by CD34 and CD117 antibodies.


Sujet(s)
Aldose reductase/antagonistes et inhibiteurs , Benzofuranes/pharmacologie , Antienzymes/pharmacologie , Uvéite/traitement médicamenteux , Animaux , Antioxydants/métabolisme , Apoptose/effets des médicaments et des substances chimiques , Benzofuranes/composition chimique , Modèles animaux de maladie humaine , Antienzymes/composition chimique , Oeil/enzymologie , Médiateurs de l'inflammation/métabolisme , Lipopolysaccharides/toxicité , Mâle , Stress oxydatif/effets des médicaments et des substances chimiques , Proteasome endopeptidase complex/métabolisme , Rats , Rat Sprague-Dawley , Tyrosine/analogues et dérivés , Tyrosine/métabolisme , Ubiquitine/métabolisme , Uvéite/métabolisme , Uvéite/anatomopathologie
8.
Clin Hemorheol Microcirc ; 54(1): 109-13, 2013 Jan 01.
Article de Anglais | MEDLINE | ID: mdl-23481597

RÉSUMÉ

Rett syndrome (RTT) is a post-natal neurological disorder that represents the second most common cause for mental retardation. The presence of cold hands and feet, and blue, a feature frequently observed in these patients, is one of the non-neurological phenotypes that characterizes RTT, up to now not well explained. We have performed videocapillaroscopy in subjects affected by Rett syndrome. We have observed ramified and bushy capillaries, characteristic features of neoangiogenic capillaries, dilated capillaries and an irregular and chaotic microvascular pattern. To quantify these features and to evaluate the microvascular pattern complexity, we have performed a fractal analysis. Fractal dimension and Lempel-Ziv indexes resulted higher in Rett females than in age-matched healthy females (p < 0.001; p < 0.001). Our findings indicate the presence of previously unrecognized microvascular abnormalities in Rett syndrome.


Sujet(s)
Syndrome de Rett/physiopathologie , Adolescent , Études cas-témoins , Enfant , Enfant d'âge préscolaire , Femelle , Fractales , Humains , Microcirculation/physiologie , Capillaroscopie/méthodes
9.
Chir Main ; 31(1): 30-3, 2012 Feb.
Article de Français | MEDLINE | ID: mdl-22365318

RÉSUMÉ

INTRODUCTION: Surgery site errors and technical errors in hand surgery are rare and not often published. OBSERVATION: A 46-year-old patient with rhizoarthrosis of the left hand was initially treated by mistake in another center by a scaphoidectomy instead of a trapezectomy. She was seen in consultation 6months later, still suffering from her rhizoarthrosis and with carpal instability, clinically symptomatic and radiologically confirmed. The instability of the wrist was treated by a hamatocapito-lunar arthrodesis and a trapeziometacarpal arthrodesis was performed to treat the rhizoarthrosis. The clinical and radiological results were acceptable. DISCUSSION: Besides the paradigmatic error, this observation confirms that the excision of the scaphoid quickly leads to a destabilization of the wrist, the capitatum no longer maintaining its alignment under the lunatum, and leads to a limitation of the wrist mobility and a loss of strength. The hamato-capito-lunate arthrodesis described in 1997 can treat wrist instability and only the trapeziometacarpal arthrodesis can, in the absence of scaphoid, treat the problem of rhizoarthrosis. CONCLUSION: The authors recommend to always carry out a radiography of the wrist during trapezectomy surgery when there is doubt about the identification of the trapezium.


Sujet(s)
Maladies articulaires/chirurgie , Erreurs médicales , Procédures orthopédiques/méthodes , Os scaphoïde/chirurgie , Os trapèze/chirurgie , Articulation du poignet , Femelle , Humains , Adulte d'âge moyen
10.
Curr Top Med Chem ; 12(4): 312-20, 2012.
Article de Anglais | MEDLINE | ID: mdl-22204489

RÉSUMÉ

Indolylglyoxylamides are a class of distinctive benzodiazepine receptor ligands, proposed in the mid-eighties as open analogues of -carbolines. Thorough and long-lasting studies of their structure-activity relationships led to the development of a great deal of derivatives, to satisfy increasingly structural and pharmacophoric requirements of the benzodiazepine binding site in the central nervous system. Efforts to pre-organize their flexible structure in the three-dimensional shape adopted when bound to the receptor led to the identification of two novel classes of rigid ligands, characterized by planar tricyclic heteroaromatic cores: the [1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one and the [1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1,5(6H)-dione. The present review focuses on these selected classes of ligands, whose rational development, in terms of chemical structures and structure-activity relationships, will be fully discussed.


Sujet(s)
Amides/composition chimique , Anxiolytiques/composition chimique , Glyoxylates/composition chimique , Hypnotiques et sédatifs/composition chimique , Indoles/composition chimique , Récepteurs GABA-A/métabolisme , Amides/pharmacologie , Animaux , Anxiolytiques/pharmacologie , Sites de fixation , Encéphale/effets des médicaments et des substances chimiques , Encéphale/métabolisme , Agonistes du récepteur GABA-A/composition chimique , Agonistes du récepteur GABA-A/pharmacologie , Antagonistes du récepteur GABA-A/composition chimique , Antagonistes du récepteur GABA-A/pharmacologie , Glyoxylates/pharmacologie , Humains , Hypnotiques et sédatifs/pharmacologie , Indoles/pharmacologie , Ligands , Liaison aux protéines , Sous-unités de protéines/agonistes , Sous-unités de protéines/antagonistes et inhibiteurs , Sous-unités de protéines/métabolisme , Relation structure-activité , Triazines/composition chimique , Triazines/pharmacologie , Triazoles/composition chimique , Triazoles/pharmacologie
11.
Curr Med Chem ; 18(19): 2893-903, 2011.
Article de Anglais | MEDLINE | ID: mdl-21651490

RÉSUMÉ

Kit is a growth factor receptor of the type III tyrosine kinase family, whose gain-of-function mutations have been identified as driving causes of different kinds of tumours. It thus represents a viable drug target, and the development of Kit inhibitors has been shown to be a promising therapeutic concept. This review will focus on structural and signalling properties of both wild-type and mutant Kit, as well as its role in the development of human cancers. Special attention will be dedicated to gastrointestinal stromal tumours, GISTs. Progress in research on the aetiopathogenesis of GISTs and their therapeutic approaches will be fully discussed, focusing on the latest tendencies for the treatment of these kinds of tumours.


Sujet(s)
Antinéoplasiques/usage thérapeutique , Tumeurs stromales gastro-intestinales/traitement médicamenteux , Tumeurs stromales gastro-intestinales/enzymologie , Inhibiteurs de protéines kinases/usage thérapeutique , Protéines proto-oncogènes c-kit/génétique , Protéines proto-oncogènes c-kit/métabolisme , Animaux , Antinéoplasiques/composition chimique , Antinéoplasiques/pharmacologie , Tumeurs stromales gastro-intestinales/génétique , Tube digestif/effets des médicaments et des substances chimiques , Tube digestif/enzymologie , Tube digestif/métabolisme , Régulation de l'expression des gènes tumoraux/effets des médicaments et des substances chimiques , Humains , Mutation/effets des médicaments et des substances chimiques , Inhibiteurs de protéines kinases/composition chimique , Inhibiteurs de protéines kinases/pharmacologie , Protéines proto-oncogènes c-kit/composition chimique
12.
Amino Acids ; 40(5): 1385-96, 2011 May.
Article de Anglais | MEDLINE | ID: mdl-21404063

RÉSUMÉ

Creatine monohydrate (Cr), the most diffuse supplement in the sports industry, is receiving greater attention because of its beneficial effects in a wide number of human degenerative diseases and conditions. These effects can be barely explained on the basis of the sole ergogenic role of the Cr/CrP system. Indeed, a wide number of research articles indicate that Cr is capable of exerting multiple, non-energy related, effects on diverse and relevant cellular targets. Among these effects, the antioxidant activity of Cr emerges as an additional mechanism which is likely to play a supportive role in the Cr-cytoprotection paradigm.


Sujet(s)
Antioxydants , Créatine , Animaux , Antioxydants/administration et posologie , Antioxydants/métabolisme , Antioxydants/pharmacologie , Créatine/administration et posologie , Créatine/métabolisme , Créatine/pharmacologie , Compléments alimentaires , Humains , Espèces réactives de l'oxygène/métabolisme
13.
Curr Top Med Chem ; 10(10): 976-92, 2010.
Article de Anglais | MEDLINE | ID: mdl-20370657

RÉSUMÉ

Adenosine is a ubiquitous homeostatic substance which exerts its action by triggering four different cell membrane G protein-coupled receptors, classified as A(1), A(2A), A(2B), and A(3). Being widely distributed and deeply involved in several physiological functions, as well as pathological disorders, these receptors represent an excellent drug target and the development of specific ligands has been tested as a promising therapeutic concept. Among the obtainable ligands, allosteric modulators offer higher advantages with respect to classical orthosteric compounds, as they possible to achieve greater selectivity and better modulatory control at disease mediating receptors. Actually, synergizing with adenosine bound to the primary binding site, these compounds may modify receptor functions through interaction with an additional binding site. As a consequence, their actions depend directly on the release of the endogenous agonist. A number of compound have been developed as effective allosteric modulators. Most of them target adenosine A(1) and A(3) receptor subtypes as, to date, little or no research attempt have been made to improve the field of A(2A) and A(2B) ligands. This review updates literature on the allosteric modulators that has appeared in the last few years, focusing its attention on medicinal chemistry, in terms of chemical structure and structure-activity relationships. This will provide new perspectives on existing data and an exciting starting point for the development of novel and more effective modulators.


Sujet(s)
Adénosine/pharmacologie , Récepteurs purinergiques P1/métabolisme , Adénosine/analogues et dérivés , Adénosine/composition chimique , Régulation allostérique/effets des médicaments et des substances chimiques , Animaux , Humains , Ligands , Agonistes des récepteurs purinergiques P1/métabolisme , Relation structure-activité
14.
Arch Ital Biol ; 145(2): 99-110, 2007 May.
Article de Anglais | MEDLINE | ID: mdl-17639782

RÉSUMÉ

Brain derived growth factor (BDNF) gene of rat has a complex structure: at least four 5' untranslated exons regulated by different promoters and one 3' exon containing the encoding region. BDNF is expressed by skeletal muscles in an activity-dependent manner. In this study, BDNF mRNA was analysed by RT-PCR in the soleus muscle following a single (acute) session of running or a training of five days of running (repetitive exercise). Moreover, the expression of the exons was quantitatively analysed by real time RT-PCR. Finally, muscle BDNF protein level was evaluated by western blotting. BDNF mRNA was found to increase over the second day after acute exercise; on the other hand, two peaks (2 and 24 hours after the last session, respectively) in BDNF mRNA level were found after repetitive exercise, but it was similar to that of controls 6 hours after the last session. BDNF protein level progressively increased also after the mRNA went back to the basal level, so suggesting that it cumulates within the cell after acute exercise, whereas it followed the mRNA level time course after repetitive exercise. These results point to the following conclusions: BDNF mRNA is up-regulated by activity, but this response is delayed to the second day after acute exercise; repetitive exercise transiently depresses the expression of BDNF mRNA, so that the over-expression due to the previous day's exercise completely disappears 6 hours after the last exercise session.


Sujet(s)
Facteur neurotrophique dérivé du cerveau/génétique , Facteur neurotrophique dérivé du cerveau/métabolisme , Régulation de l'expression des gènes/physiologie , Muscles squelettiques/métabolisme , Conditionnement physique d'animal/physiologie , Épissage alternatif/génétique , Animaux , Régulation négative/physiologie , Épreuve d'effort , Mâle , Isoformes de protéines/génétique , Isoformes de protéines/métabolisme , ARN messager/métabolisme , Rats , Rat Sprague-Dawley , RT-PCR , Facteurs temps , Régulation positive/physiologie
15.
Hand Clin ; 19(4): 631-48, vii, 2003 Nov.
Article de Anglais | MEDLINE | ID: mdl-14596554

RÉSUMÉ

The authors report a simple chart that offers a comprehensive picture of spasticity of the upper limb and provides a more objective method of recording data. Distinction is made between fixed postures and the residual active range of motion at the shoulder and elbow. The presence and function of the muscles can be identified easily on dynamic EMG studies, which are essential for understanding the degree of spasticity and dyssynergy related to a single muscle. When spasticity of the upper arm is managed with a global approach and objectives are defined clearly in advance with the patient and caregivers, treatment of shoulder and elbow deformities can achieve important results for personal hygiene or functional targets.


Sujet(s)
Paralysie cérébrale/chirurgie , Coude/chirurgie , Épaule/chirurgie , Activités de la vie quotidienne , Adolescent , Adulte , Sujet âgé , Paralysie cérébrale/physiopathologie , Évaluation de l'invalidité , Coude/physiopathologie , Électromyographie , Femelle , Hémiplégie/physiopathologie , Hémiplégie/chirurgie , Humains , Mâle , Adulte d'âge moyen , Soins préopératoires , Tétraplégie/physiopathologie , Tétraplégie/chirurgie , Rotation , Épaule/physiopathologie , Résultat thérapeutique
16.
Somatosens Mot Res ; 19(4): 279-85, 2002.
Article de Anglais | MEDLINE | ID: mdl-12590829

RÉSUMÉ

Primary sensory neurons project to motor neurons directly or through interneurons and affect their activity. In our previous paper we showed that intramuscular sprouting can be affected by changing the sensory synaptic input to motor neurons. In this work, motor axon sprouting within a peripheral nerve (extramuscular sprouting) was induced by nerve injury at such a distance from muscle so as not to allow nerve-muscle trophic interactions. Two different procedures were carried out: (1) sciatic nerve crush and (2) sciatic nerve crush with homosegmental ipsilateral L3-L5 dorsal rhizotomy. The number of regenerating motor axons innervating extensor digitorum longus muscle was determined by in vivo muscle tension recordings and an index of their individual conduction rate was obtained by in vitro intracellular recordings of excitatory postsynaptic end-plate potentials in muscle fibers. The main findings were: (1) there are more regenerated axons distally from the lesion than parent axons proximally to the lesion (sprouting at the lesion); (2) sprouting at the lesion was negatively affected by homosegmental ipsilateral dorsal rhizotomy; (3) the number of motor axons innervating extensor digitorum longus muscle extrafusal fibers counted proximally to the lesion increased following nerve injury and regeneration but this did not occur when sensory input was lost. A transient innervation of extrafusal fibers by gamma motor neurons may explain the increase of motor axons counted proximally to the lesion.


Sujet(s)
Motoneurones/physiologie , Régénération nerveuse/physiologie , Plasticité neuronale/physiologie , Nerfs périphériques/physiologie , Terminaisons présynaptiques/physiologie , Cellules réceptrices sensorielles/physiologie , Animaux , Potentiels post-synaptiques excitateurs/physiologie , Latéralité fonctionnelle/physiologie , Ganglions sensitifs des nerfs spinaux/physiologie , Mâle , Plaque terminale motrice/physiologie , Muscles squelettiques/innervation , Écrasement de nerf , Conduction nerveuse/physiologie , Lésions des nerfs périphériques , Rats , Rat Sprague-Dawley , Rhizotomie , Nerf ischiatique
17.
Neurosci Lett ; 286(1): 21-4, 2000 May 26.
Article de Anglais | MEDLINE | ID: mdl-10822143

RÉSUMÉ

Neurogenesis occurs throughout life in mammalian dentate gyrus. The effect of learning on newborn cell survival was studied in rat. Rats were trained on a hippocampus-dependent spatial learning task by using Morris water maze. Neurogenesis was evaluated by 5-bromo-2'deoxyuridine administered before learning. Several newborn cells expressed the immature neuron marker TOAD-64. The main findings were as follows: (1) the survival of newborn cells was enhanced by learning at early stage of differentiation; (2) the newborn cells saved by learning were mainly located in the rostral part of external blade of granule cell layer and (3) there was a correlation between the actual individual learning and newborn cell survival.


Sujet(s)
Division cellulaire/physiologie , Survie cellulaire/physiologie , Gyrus denté/cytologie , Gyrus denté/croissance et développement , Apprentissage du labyrinthe/physiologie , Neurones/cytologie , Neurones/métabolisme , Perception de l'espace/physiologie , Comportement spatial/physiologie , Facteurs âges , Animaux , Antimétabolites/pharmacologie , Marqueurs biologiques , Broxuridine/pharmacologie , Numération cellulaire , Gyrus denté/métabolisme , Mâle , Rats , Rat Sprague-Dawley
18.
Neurosci Lett ; 275(1): 29-32, 1999 Nov 05.
Article de Anglais | MEDLINE | ID: mdl-10554977

RÉSUMÉ

The control of peripheral structural plasticity of motor neurons by primary sensory neurons was studied in rat extensor digitorum longus (EDL) muscle. Polyinnervation of muscle fibers, sprouting and the motor neuron peripheral field size following L4 dorsal root cutting were evaluated using three different approaches: intracellular recording of end plate potentials, histochemical demonstration of sprouting and polyinnervation and in vivo recording of nerve-evoked twitch. Nodal sprouting was found in rhizotomized rats but not in controls and consistently muscle polyinnervation appeared. The muscle portion innervated by L3 ventral root was relatively reduced and that innervated by L5 was relatively enlarged: a trend to caudal shift of muscle innervation arose in rhizotomized rats. A control of motor neuron plasticity by primary sensory neurons is suggested.


Sujet(s)
Motoneurones/physiologie , Plasticité neuronale/physiologie , Neurones afférents/physiologie , Animaux , Potentiels post-synaptiques excitateurs , Histocytochimie , Techniques in vitro , Mâle , Muscles squelettiques/innervation , Rats , Rat Sprague-Dawley , Rhizotomie
19.
Pharmacopsychiatry ; 32(4): 136-41, 1999 Jul.
Article de Anglais | MEDLINE | ID: mdl-10505483

RÉSUMÉ

OBJECTIVE: Open studies and case observations have suggested that gabapentin may be effective in the treatment of bipolar disorder. However, the adjunctive use of the drug in bipolar mixed states has not been specifically addressed before. METHODS: Twenty-one patients with bipolar I mixed episodes as defined by Diagnostic and Statistical Manual of Mental Disorders (Revised) (DSM-III-R), who were admitted to the outpatient department at the Psychiatry Clinic of the University of Pisa, were treated adjunctively with gabapentin for a period of eight weeks. All patients had been resistant to therapeutic levels of standard mood stabilizers, and had a mean clinical global impression (CGI) of 5.2+/-0.8 when entering the study. Gabapentin treatment was started at 300 mg/day and increased up to 2000 mg/day. Patients were evaluated using the Hamilton Rating Scale for Depression (HRSD), the Young Mania Rating Scale (YMRS), and CGI. Patients with final CGI scores of 1 or 2 were regarded as responders. RESULTS: Only one patient had to interrupt the drug treatment, due to irritability and ataxia. Negative interactions between gabapentin and concomitant psychotropic medications were not observed. The condition deteriorated in only one patient (final CGI = 5). Ten patients were regarded as responders: four showed marked improvement (CGI = 1), and six had moderate improvement (CGI = 2). The mean dose of gabapentin at week 8 was 1130 mg (range 600-2000 mg). The mean final CGI score for all patients (responders and nonresponders combined) was 3.7+/-1.1 (the mean change in CGI was significant, t=6.1, P<0001). The reduction in the mania score was minimal and statistically insignificant. However, the mean HRSD score showed a statistically significant reduction from 18.2 to 10.6 (t=5.73, P<0.0001), irrespective of the baseline severity of the mania. All but one of the responders maintained these therapeutic improvements over 4-12 months, in most cases requiring less concomitant antidepressant and neuroleptic medications. CONCLUSIONS: These results show that gabapentin appears to be potentially useful in the adjunctive treatment of drug-resistant bipolar mixed states, and that it was particularly effective in relation to depressive symptomatology.


Sujet(s)
Acétates/usage thérapeutique , Amines , Antimaniacodépressifs/usage thérapeutique , Trouble bipolaire/traitement médicamenteux , Acides cyclohexanecarboxyliques , Acide gamma-amino-butyrique , Adjuvants pharmaceutiques/usage thérapeutique , Adulte , Sujet âgé , Analyse de variance , Antidépresseurs/usage thérapeutique , Résistance aux substances , Association de médicaments , Femelle , Gabapentine , Humains , Mâle , Adulte d'âge moyen , Résultat thérapeutique
20.
J Submicrosc Cytol Pathol ; 31(1): 31-40, 1999 Jan.
Article de Anglais | MEDLINE | ID: mdl-10363353

RÉSUMÉ

The role of N-methyl-D-aspartic acid receptors (NMDARs) of glutamate on neuritogenesis was studied in cultured neurons of chick embryo spinal cord using the NMDAR non-competitive antagonist dizocilpine maleate (MK-801). No cell population was fully prevented from neuritogenesis by MK-801. Different aspects of neuritogenesis were quantitatively evaluated. Neurite initiation, elongation and branching were depressed by MK-801. Inhibition was dose-dependent and reversible. A loss of responsiveness of neuritogenesis to MK-801 was found during the second day of treatment at a concentration of 10 microM, but not at higher concentrations. Our findings support the idea that Ca2+ influx through NMDAR associated channels is one of the possible triggers of a cascade resulting in neuritogenesis. The effects of NMDAR blocking on neuritogenesis occurred before synaptogenesis, suggesting a role of excitatory aminoacids in neuron morphological differentiation at early stages of development. Scanning electron microscopy confirmed a reduction in neurite tree complexity in MK-801 treated cells and showed a production of filopodium-like processes in some of these cells.


Sujet(s)
Maléate de dizocilpine/pharmacologie , Neurites/physiologie , Neurones/cytologie , Récepteurs du N-méthyl-D-aspartate/physiologie , Moelle spinale/cytologie , Animaux , Calcium/métabolisme , Cellules cultivées , Embryon de poulet , Microscopie électronique à balayage , Neurites/effets des médicaments et des substances chimiques , Neurites/ultrastructure , Neurones/effets des médicaments et des substances chimiques , Neurones/physiologie , Récepteurs du N-méthyl-D-aspartate/effets des médicaments et des substances chimiques , Moelle spinale/physiologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE